These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1110 related items for PubMed ID: 22421353

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W, Hao Z, Han JL, Zhu DJ, Jin ZF, Xie WL.
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition.
    Jing Y, Cui D, Guo W, Jiang J, Jiang B, Lu Y, Zhao W, Wang X, Jiang Q, Han B, Xia S.
    Cancer Lett; 2014 Jun 28; 348(1-2):135-45. PubMed ID: 24662746
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Slug is a key mediator of hypoxia induced cadherin switch in HNSCC: correlations with poor prognosis.
    Zhang J, Cheng Q, Zhou Y, Wang Y, Chen X.
    Oral Oncol; 2013 Nov 28; 49(11):1043-50. PubMed ID: 24035721
    [Abstract] [Full Text] [Related]

  • 13. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
    Wallerand H, Cai Y, Wainberg ZA, Garraway I, Lascombe I, Nicolle G, Thiery JP, Bittard H, Radvanyi F, Reiter RR.
    Urol Oncol; 2010 Nov 28; 28(2):180-8. PubMed ID: 19070520
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F, Zhang MR, Zhou Z, Pu JX, Zhao XJ.
    J Cell Biochem; 2019 Jun 28; 120(6):10821-10829. PubMed ID: 30672010
    [Abstract] [Full Text] [Related]

  • 16. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
    Jitao W, Jinchen H, Qingzuo L, Li C, Lei S, Jianming W, Zhenli G.
    Andrologia; 2014 Dec 28; 46(10):1128-33. PubMed ID: 24329492
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
    Wang ZY, Zeng FQ, Zhu ZH, Jiang GS, Lv L, Wan F, Dong R, Xiao XY, Xing SA.
    Urol Oncol; 2012 Dec 28; 30(2):167-76. PubMed ID: 20864366
    [Abstract] [Full Text] [Related]

  • 18. Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells.
    Kim CJ, Sakamoto K, Tambe Y, Inoue H.
    Int J Oncol; 2011 Jun 28; 38(6):1759-66. PubMed ID: 21468544
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 56.